RECORD // Company

Invivyd, Inc.

Formerly: Adagio Therapeutics, Inc.

Built 2026-11-22T00:29:38Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (10)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Invivyd, Inc. · Ct business · same registered legal name as 'Invivyd, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Invivyd, Inc. · Ctgov · same registered legal name as 'Invivyd, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • INVIVYD, INC. · East licences · same registered legal name as 'Invivyd, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • INVIVYD, INC. · East licences · same registered legal name as 'Invivyd, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • INVIVYD, INC. · East licences · same registered legal name as 'Invivyd, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • INVIVYD, INC. (lobbying via CGCN GROUP, LLC) · LDA lobbying · same registered legal name as 'Invivyd, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • INVIVYD, INC. (lobbying via EAST END GROUP, LLC) · LDA lobbying · same registered legal name as 'Invivyd, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • INVIVYD, INC. (lobbying via INVIVYD, INC.) · LDA lobbying · same registered legal name as 'Invivyd, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • INVIVYD, INC. (lobbying via KING & SPALDING LLP) · LDA lobbying · same registered legal name as 'Invivyd, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • INVIVYD, INC. · USAspending · same registered legal name as 'Invivyd, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

3 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001193125-26-462034

ItemValuePeriodFormFiledAccessionReport
Revenue$15,449,0003 months ended 2026-09-3010-Q2026-11-160001193125-26-4620342026-11-22 00:29 UTCReport an error
Net income (loss)$-33,468,0003 months ended 2026-09-3010-Q2026-11-160001193125-26-4620342026-11-22 00:29 UTCReport an error
Cash and cash equivalents$126,398,000at 2026-09-3010-Q2026-11-160001193125-26-4620342026-11-22 00:29 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001832038
Ticker
IVVD
EIN
851403134
CUSIP
00534A102
Record ID
sx:sec:0001832038

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

33 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 00:29 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-16SEC EDGAR company profile2026-11-22 00:29 UTCReport an error
State of incorporationDE2026-11-16SEC EDGAR company profile2026-11-22 00:29 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-22 00:29 UTCReport an error
Business address205 CHURCH STREET, NEW HAVEN, CT2026-11-16SEC EDGAR company profile2026-11-22 00:29 UTCReport an error
ExchangesNasdaq2026-11-16SEC EDGAR company profile2026-11-22 00:29 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$53,426,0002025-12-3110-K, XBRL Revenues2026-11-22 00:29 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-52,489,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-22 00:29 UTCReport an error
Total assets (at 2025-12-31)$276,883,0002025-12-3110-K, XBRL Assets2026-11-22 00:29 UTCReport an error
Stockholders' equity (at 2025-12-31)$241,540,0002025-12-3110-K, XBRL StockholdersEquity2026-11-22 00:29 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$226,689,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 00:29 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-58,135,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 00:29 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$155,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 00:29 UTCReport an error
Operating lease liabilities (at 2025-12-31)$1,335,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 00:29 UTCReport an error
Form D total offering amount (D filed 2022-11-29)$23,749,9982022-11-29D2026-11-22 00:29 UTCReport an error
Form D total amount sold (D filed 2022-11-29)$23,749,9982022-11-29D2026-11-22 00:29 UTCReport an error
Form D industry groupBiotechnology2022-11-29D2026-11-22 00:29 UTCReport an error
Form D revenue rangeDecline to Disclose2022-11-29D2026-11-22 00:29 UTCReport an error
Form D date of first sale2022-11-152022-11-29D2026-11-22 00:29 UTCReport an error
8-K Item 2.02 (filed 2026-11-16)Results of Operations and Financial Condition. On November 16, 2026, Invivyd, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2026, and recent business highlights. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 2.02. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference…2026-11-16SEC EDGAR 8-K 0001193125-26-462025 (text as filed, excerpt)2026-11-22 00:29 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-09-29)On September 29, 2026, Invivyd, Inc. (the “Company”) issued a press release entitled “Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311.” A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01. On September 29, 2026, the Company posted an updated corporate presentation on its website at www.invivyd.com. A copy of the presentation is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01.2026-09-29SEC EDGAR 8-K 0001193125-26-406007 (text as filed, excerpt)2026-11-22 00:29 UTCReport an error
8-K Item 2.02 (filed 2026-08-13)Results of Operations and Financial Condition. On August 13, 2026, Invivyd, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2026, and recent business highlights. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 2.02. The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into…2026-08-13SEC EDGAR 8-K 0001193125-26-349193 (text as filed, excerpt)2026-11-22 00:29 UTCReport an error
Plan (pension, plan no. 001)INVIVYD, INC. 401(K) PLAN: 165 participants, assets $13,072,0292025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-22 00:29 UTCReport an error
Largest institutional holder #1 (13F as filed): Jupiter Topco LLC$30,048,4102026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:29 UTCReport an error
Largest institutional holder #2 (13F as filed): BVF INC/IL$24,571,1462026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:29 UTCReport an error
Largest institutional holder #3 (13F as filed): MAVERICK CAPITAL LTD$16,550,2252026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:29 UTCReport an error
Largest institutional holder #4 (13F as filed): PERCEPTIVE ADVISORS LLC$16,131,2312026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:29 UTCReport an error
Largest institutional holder #5 (13F as filed): BlackRock, Inc.$14,076,0732026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:29 UTCReport an error
Largest institutional holder #6 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$9,152,9542026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:29 UTCReport an error
Largest institutional holder #7 (13F as filed): M28 Capital Management LP$8,068,1732026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:29 UTCReport an error
Largest institutional holder #8 (13F as filed): Saturn V Capital Management LP$7,321,4322026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:29 UTCReport an error
Largest institutional holder #9 (13F as filed): Soleus Capital Management, L.P.$6,725,0932026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:29 UTCReport an error
Largest institutional holder #10 (13F as filed): Point72 Asset Management, L.P.$6,579,6942026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:29 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.